{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:50:22Z","timestamp":1762501822000,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019111","name":"Perron Institute for Neurological and Translational Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bbrep.2022.101305","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T17:54:26Z","timestamp":1656698066000},"page":"101305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in ex vivo models of mast cell degranulation and red blood cell hemolysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Adam B.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank L.","family":"Mastaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neville W.","family":"Knuckey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Ho","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2022.101305_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fneur.2020.00108","article-title":"Cationic arginine-rich peptides (CARPs): a novel class of neuroprotective agents with a multimodal mechanism of action","volume":"11","author":"Meloni","year":"2020","journal-title":"Front. Neurol."},{"year":"2015","author":"Meloni","series-title":"Poly-arginine and Arginine-Rich Peptides Are Neuroprotective in Stroke Models","key":"10.1016\/j.bbrep.2022.101305_bib2"},{"key":"10.1016\/j.bbrep.2022.101305_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pharmthera.2015.06.002","article-title":"Neuroprotective peptides fused to arginine-rich cell penetrating peptides: neuroprotective mechanism likely mediated by peptide endocytic properties","volume":"153","author":"Meloni","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bbrep.2022.101305_bib4","doi-asserted-by":"crossref","first-page":"e0193884","DOI":"10.1371\/journal.pone.0193884","article-title":"Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies","volume":"13","author":"Milani","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbrep.2022.101305_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12868-016-0253-z","article-title":"Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model","volume":"17","author":"Milani","year":"2016","journal-title":"BMC Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.bbrep.2022.101305_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12017-017-8441-2","article-title":"Assessment of the neuroprotective effects of arginine-rich protamine peptides, poly-arginine peptides (R12-Cyclic, R22) and arginine\u2013tryptophan-containing peptides following in vitro excitotoxicity and\/or permanent middle cerebral artery occlusion in rats","volume":"19","author":"Meloni","year":"2017","journal-title":"NeuroMolecular Med."},{"year":"2021","author":"Milani","series-title":"Comparative Assessment of the Proteolytic Stability and Impact of Poly-Arginine Peptides R18 and R18D on Infarct Growth and Penumbral Tissue Preservation Following Middle Cerebral Artery Occlusion in the Sprague Dawley Rat","key":"10.1016\/j.bbrep.2022.101305_bib7"},{"key":"10.1016\/j.bbrep.2022.101305_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2372710","article-title":"The R18 polyarginine peptide is more effective than the TAT-NR2B9c (NA-1) peptide when administered 60 minutes after permanent middle cerebral artery occlusion in the rat","volume":"2016","author":"Milani","year":"2016","journal-title":"Stroke Res. Treat."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101305_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13041-018-0352-0","article-title":"Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat","volume":"11","author":"Edwards","year":"2018","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbrep.2022.101305_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.24315","article-title":"Assessment of therapeutic window for poly-arginine-18D (R18D) in a P7 rat model of perinatal hypoxic-ischaemic encephalopathy","author":"Edwards","year":"2018","journal-title":"Accept. J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101305_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1515\/tnsci-2017-0021","article-title":"Assessment of R18, COG1410, and APP96-110 in excitotoxicity and traumatic brain injury","volume":"8","author":"Chiu","year":"2017","journal-title":"Transl. Neurosci."},{"year":"2019","author":"Meloni","series-title":"Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model","key":"10.1016\/j.bbrep.2022.101305_bib12"},{"issue":"6","key":"10.1016\/j.bbrep.2022.101305_bib13","doi-asserted-by":"crossref","first-page":"e00547","DOI":"10.1002\/prp2.547","article-title":"MrgX2 is a promiscuous receptor for basic peptides causing mast cell pseudo-allergic and anaphylactoid reactions","volume":"7","author":"Grimes","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"issue":"5","key":"10.1016\/j.bbrep.2022.101305_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.11.030","article-title":"Mechanisms of vitamin D3 metabolite repression of IgE-dependent mast cell activation","volume":"133","author":"Yip","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2022.101305_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bbrc.2012.07.074","article-title":"Mast cell degranulation mediates compound 48\/80-induced hyperalgesia in mice","volume":"425","author":"Chatterjea","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bbrep.2022.101305_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2567.2007.02705.x","article-title":"Neuropeptides activate human mast cell degranulation and chemokine production","volume":"123","author":"Kulka","year":"2008","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.bbrep.2022.101305_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/mi.2013.37","article-title":"Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor","volume":"7","author":"Pundir","year":"2013","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101305_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)21370-2","article-title":"Activation of rat peritoneal mast cells by substance P and Mastoparan1","volume":"250","author":"Mousli","year":"1989","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"10227","key":"10.1016\/j.bbrep.2022.101305_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial","volume":"395","author":"Hill","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bbrep.2022.101305_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22101693","article-title":"Large-scale oral treatment study with the four most promising D3-derivatives for the treatment of Alzheimer's disease","volume":"22","author":"Kutzsche","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bbrep.2022.101305_bib21","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3233\/JAD-191185","article-title":"The MARBLE study protocol: modulating ApoE signaling to reduce brain inflammation, DeLirium, and PostopErative cognitive dysfunction","volume":"75","author":"Vandusen","year":"2020","journal-title":"J. Alzheimers. Dis."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101305_bib22","doi-asserted-by":"crossref","first-page":"e00020","DOI":"10.1002\/prp2.20","article-title":"XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study","volume":"2","author":"Deloche","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"issue":"3","key":"10.1016\/j.bbrep.2022.101305_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1213\/00000539-198503000-00008","article-title":"Protamine: a review of its toxicity","volume":"64","author":"Horrow","year":"1985","journal-title":"Anesth. Analg."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101305_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1464-5491.2004.01352.x","article-title":"A rational clinical approach to suspected insulin allergy: status after five years and 22 cases","volume":"22","author":"Bodtger","year":"2005","journal-title":"Diabet. Med."},{"issue":"14","key":"10.1016\/j.bbrep.2022.101305_bib25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJM198904063201402","article-title":"Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine","volume":"320","author":"Weiss","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bbrep.2022.101305_bib26","first-page":"277","article-title":"Adverse reactions to protamine sulfate during cardiac surgery in diabetic and non-diabetic patients","volume":"61","author":"Gottschlich","year":"1988","journal-title":"Ann. Allergy"},{"issue":"5","key":"10.1016\/j.bbrep.2022.101305_bib27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.70.5.788","article-title":"Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization","volume":"70","author":"Stewart","year":"1984","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.bbrep.2022.101305_bib28","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1128\/IAI.01497-08","article-title":"Histamine plays an essential regulatory role in lung inflammation and protective immunity in the acute phase of Mycobacterium tuberculosis infection","volume":"77","author":"Carlos","year":"2009","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.bbrep.2022.101305_bib29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ni.2109","article-title":"Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils","volume":"12","author":"Galli","year":"2011","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2022.101305_bib30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaci.2020.12.655","article-title":"A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice","volume":"148","author":"Wolf","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2022.101305_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/exd.14222","article-title":"MRGPRX2 sensing of cationic compounds-A bridge between nociception and skin diseases?","volume":"30","author":"Corbi\u00e8re","year":"2021","journal-title":"Exp. Dermatol."},{"year":"2008","author":"Tymianski","series-title":"Co-administration of an Agent Linked to an Internalization Peptide with an Anti-inflammatory","key":"10.1016\/j.bbrep.2022.101305_bib32"},{"year":"2019","author":"Tymianski","series-title":"Co-administration of an Agent Linked to an Internalization Peptide with an Anti-inflammatory,\u201d US20190038760A1","key":"10.1016\/j.bbrep.2022.101305_bib33"},{"issue":"12","key":"10.1016\/j.bbrep.2022.101305_bib34","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.tibs.2015.10.004","article-title":"Mechanism matters: a taxonomy of cell penetrating peptides","volume":"40","author":"Kauffman","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"Pt 2","key":"10.1016\/j.bbrep.2022.101305_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1042\/BJ20150272","article-title":"Efficient entry of cell-penetrating peptide nona-arginine into adherent cells involves a transient increase in intracellular calcium","volume":"471","author":"Melikov","year":"2015","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bbrep.2022.101305_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00000542-199007000-00022","article-title":"Protamine-induced histamine release in human skin mast cells","volume":"73","author":"Sauder","year":"1990","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbrep.2022.101305_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.actbio.2021.09.011","article-title":"Identification of short peptide sequences that activate human mast cells via Mas-related G-protein coupled receptor member X2","volume":"136","author":"Lu","year":"2021","journal-title":"Acta Biomater."},{"issue":"2\u20133","key":"10.1016\/j.bbrep.2022.101305_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(99)00411-1","article-title":"A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides","volume":"449","author":"Helmerhorst","year":"1999","journal-title":"FEBS Lett."},{"issue":"21","key":"10.1016\/j.bbrep.2022.101305_bib39","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cmdc.201700498","article-title":"(R-X-R)4-Motif peptides containing conformationally constrained cyclohexane-derived spacers: effect on cellular uptake","volume":"12","author":"Bhosle","year":"2017","journal-title":"ChemMedChem"},{"issue":"16","key":"10.1016\/j.bbrep.2022.101305_bib40","doi-asserted-by":"crossref","first-page":"18363","DOI":"10.1021\/acsami.0c02752","article-title":"Structural superiority of guanidinium-rich, four-armed copolypeptides: role of multiple peptide-membrane interactions in enhancing bacterial membrane perturbation and permeability","volume":"12","author":"Wang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580822001054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580822001054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:47:37Z","timestamp":1762501657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580822001054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"alternative-id":["S2405580822001054"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2022.101305","relation":{},"ISSN":["2405-5808"],"issn-type":[{"type":"print","value":"2405-5808"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in ex vivo models of mast cell degranulation and red blood cell hemolysis","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2022.101305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101305"}}